A normative computational model of individual differences in mouse exploration driven by reward and threat uncertainty as well as risk sensitivity when faced with a novel object in an open field.

Interstellar comet 3I/ATLAS, the third confirmed visitor, reveals shocking data: high nickel content and unique cryovolcanism ...

D-Wave Quantum (NYSE: QBTS) is a pure-play quantum AI stock whose shares have rocketed by 677% over the last year -- ...

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily ...

Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease December 1, 2025 8:00 ...

Total social media time does not significantly affect adolescents' weight concerns or dieting frequency, according to the study's findings. New research reveals that total social media use does not ...

Blackstone, Apollo, KKR, Ares Management, and CVC are among the firms that have volunteered to take part in the assessment, according to a Monday report by the Financial Times, which is expected to be ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

Thompson stated, "Intersecting two mineralized porphyry systems with our first-ever drill holes at both Catalyst and Tempest ...

Mirum Pharmaceuticals, Inc. , a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 clinical study evaluating MRM-3379 in Fragile X syndrome ...

VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / Storm Exploration Inc. ("Storm" or the "Company") is pleased to announce ...